Laser Therapy for Brain Tumor

This trial tests a treatment called Laser Interstitial Thermal Therapy (LITT) to evaluate its effectiveness for children, teens, and young adults with recurring or worsening low-grade gliomas, a type of brain tumor. The goal is to determine if LITT can effectively treat these tumors when previous treatments have failed. Individuals with recurrent brain tumors that LITT can safely access, and who have already tried at least one other treatment, might be suitable candidates. Participants will undergo close monitoring and must provide health information during and after the treatment. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new treatment options.

The trial protocol does not specify if you need to stop taking your current medications. However, you must have recovered from any recent chemotherapy or targeted therapy, and there are specific waiting periods after certain treatments before you can join the study.

Research has shown that Laser Interstitial Thermal Therapy (LITT) is generally safe for treating brain tumors. A review of 45 studies found that about 30% of patients experienced side effects, with swelling, weakness, and seizures being the most common, though usually temporary. The data also indicate that LITT effectively targets tumors, achieving success rates as high as 94.8% in removing tumor tissue. While complications can occur, patients often tolerate LITT well. It is important to consult a doctor to understand how these findings apply to individual cases.¹²³⁴⁵

Laser Interstitial Thermal Therapy (LITT) is unique because it uses precise laser technology to target and destroy brain tumor tissues while sparing surrounding healthy brain tissue. Unlike traditional surgery, which can be more invasive, LITT is a minimally invasive procedure, potentially leading to faster recovery times and fewer complications. Researchers are excited about LITT because it offers a more targeted approach, which could improve outcomes and quality of life for patients with brain tumors.

Studies have shown that Laser Interstitial Thermal Therapy (LITT), which participants in this trial will receive, can effectively treat brain tumors. Research indicates that LITT can extend survival for patients with hard-to-reach brain tumors, outperforming mere tumor sampling. One study found that LITT increased the average survival time by more than six months. Another study reported that LITT successfully removed 94.8% of tumors in certain types of brain cancer. These results suggest that LITT can be a strong option for managing recurrent or persistent brain tumors.¹⁴⁶⁷⁸